Gilli Galore-Haskel

Genome-wide association study identifies three loci associated with melanoma risk

D. Timothy Bishop, Florence Démenais, Mark M. Iles et al. · Nature Genetics · 2009 · 464 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme

Gilli Galore-Haskel, Yael Nemlich, Eyal Greenberg et al. · Oncotarget · 2015 · 62 citations · Full text

Medicine, Immunology, Oncology +17

CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy

Sivan Sapoznik, Rona Ortenberg, Gilli Galore-Haskel et al. · Cancer Immunology Immunotherapy · 2012 · 56 citations · Full text

Medicine, Immunology, Oncology +15

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation

Sharon Hassin‐Baer, Yael Laitman, Esther Azizi et al. · Journal of Neurology · 2009 · 52 citations

Life Sciences, Genetics, Molecular Biology +7

CEACAM1 Promotes Melanoma Cell Growth through Sox-2

Rona Ortenberg, Gilli Galore-Haskel, Ilanit Greenberg et al. · Neoplasia · 2014 · 34 citations · Full text

Medicine, Molecular Biology, Oncology +17